Unknown

Dataset Information

0

Primary Splenic Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review of a Rare Condition.


ABSTRACT:

Introduction

Primary splenic lymphoma is a rare lymphoproliferative disorder that involves the spleen, exhibits diverse clinical presentations, and lacks a clear consensus in terms of management strategies.

Case presentation

We present the case of a 52-year-old patient with a complex medical history marked by multiple chronic medical conditions. The patient was diagnosed with primary splenic lymphoma, specifically the diffuse large B-cell subtype. Treatment for our patient involved a shortened course of chemotherapy (4 cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP] followed by two doses of rituximab) due to issues related to compliance and treatment-related complications. This was followed by consolidative radiotherapy without resorting to splenectomy.

Conclusion

Remarkably, despite using a shortened course of R-CHOP, the patient achieved complete resolution, and a positron emission tomography scan conducted at the end of the 6-month posttreatment period confirmed sustained complete remission.

SUBMITTER: Seijari MN 

PROVIDER: S-EPMC10919911 | biostudies-literature | 2024 Jan-Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Primary Splenic Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review of a Rare Condition.

Seijari Mohammed Najdat MN   Kaspo Samer S   Alshurafa Awni A   Elfaieg Amro A   Elkourashy Sarah A SA  

Case reports in oncology 20240101 1


<h4>Introduction</h4>Primary splenic lymphoma is a rare lymphoproliferative disorder that involves the spleen, exhibits diverse clinical presentations, and lacks a clear consensus in terms of management strategies.<h4>Case presentation</h4>We present the case of a 52-year-old patient with a complex medical history marked by multiple chronic medical conditions. The patient was diagnosed with primary splenic lymphoma, specifically the diffuse large B-cell subtype. Treatment for our patient involve  ...[more]

Similar Datasets

| S-EPMC11688220 | biostudies-literature
| S-EPMC6588832 | biostudies-literature
| S-EPMC11557305 | biostudies-literature
| S-EPMC3739230 | biostudies-literature